Shares of Diabetes-related Stocks Closed Lower Following Data From Lilly Showing Weekly Tirzepatide Injections Reduced the Risk of Progression to Type 2 Diabetes by 94% in Adults With Pre-diabetes and Obesity
與糖尿病相關的股票收盤下跌，因莉莉公司的數據顯示，周替格列普肽注射對於患有糖尿病前期和肥胖症的成年人降低罹患2型糖尿病的風險達94%。